Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer - Comment

被引：0
|
作者：
Ost, E
Illiger, HJ
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2002年 / 178卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [1] Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer
    Piccart, MJ
    Di Leo, A
    Beauduin, M
    Vindevoghel, A
    Michel, J
    Focan, C
    Tagnon, A
    Ries, F
    Gobert, P
    Finet, C
    Closon-Dejardin, MT
    Dufrane, JP
    Kerger, J
    Liebens, F
    Beauvois, S
    Bartholomeus, S
    Dolci, S
    Lobelle, JP
    Paesmans, M
    Nogaret, JM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3103 - 3110
  • [2] Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
    Kimura, Morihiko
    Tominaga, Takeshi
    Takatsuka, Yuichi
    Toi, Masakazu
    Abe, Rikiya
    Koyama, Hiroki
    Takashima, Shigemitsu
    Nomura, Yasuo
    Miura, Shigeto
    Kimijima, Izo
    Tashiro, Hideya
    Ohashi, Yasuo
    [J]. BREAST CANCER, 2010, 17 (03) : 190 - 198
  • [3] Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
    Morihiko Kimura
    Takeshi Tominaga
    Yuichi Takatsuka
    Masakazu Toi
    Rikiya Abe
    Hiroki Koyama
    Shigemitsu Takashima
    Yasuo Nomura
    Shigeto Miura
    Izo Kimijima
    Hideya Tashiro
    Yasuo Ohashi
    [J]. Breast Cancer, 2010, 17 : 190 - 198
  • [4] Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer
    Levine, MN
    Bramwell, VH
    Pritchard, KI
    Norris, BD
    Shepherd, LE
    Abu-Zahra, H
    Findlay, B
    Warr, D
    Bowman, D
    Myles, J
    Arnold, A
    Vandenberg, T
    MacKenzie, R
    Robert, J
    Ottaway, J
    Burnell, M
    Williams, CK
    Tu, DS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2651 - 2658
  • [5] Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide (EC or HEC) with cyclophosphamide, methotrexate, and fluorouracil (CMF) in 777 women with node-positive (N plus ) breast cancer (BC): 10-year follow-up results.
    Azambuja, E.
    Paesmans, M.
    Bernard-Marty, C.
    Beauduin, M.
    Vindevoghel, A.
    Cornez, N.
    Focan, C.
    Tagnon, A.
    Nogaret, J. M.
    Piccart-Gebhart, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 19S - 19S
  • [6] Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: Results of a randomized trial
    Coombes, RC
    Bliss, JM
    Wils, J
    Morvan, F
    Espie, M
    Amadori, D
    Gambrosier, P
    Richards, M
    Aapro, M
    VillarGrimalt, A
    McArdle, C
    PerezLopez, FR
    Vassilopoulos, P
    Ferreira, EP
    Chilvers, CED
    Coombes, G
    Woods, EM
    Marty, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 35 - 45
  • [7] Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancer
    Radice, D
    Redaelli, A
    [J]. PHARMACOECONOMICS, 2005, 23 (01) : 69 - 75
  • [8] Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancer
    Davide Radice
    Alberto Redaelli
    [J]. PharmacoEconomics, 2005, 23 : 69 - 75
  • [9] Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
    Levine, MN
    Pritchard, KL
    Bramwell, VHC
    Shepherd, LE
    Tu, DS
    Paul, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5166 - 5170
  • [10] 5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial
    Del Mastro, Lucia
    Levaggi, Alessia
    Michelotti, Andrea
    Cavazzini, Giovanna
    Adami, Francesca
    Scotto, Tiziana
    Piras, Margherita
    Danese, Saverio
    Garrone, Ornella
    Durando, Antonio
    Accortanzo, Valeria
    Bighin, Claudia
    Miglietta, Loredana
    Pastorino, Simona
    Pronzato, Paolo
    Castiglione, Federico
    Landucci, Elisabetta
    Conte, PierFranco
    Bruzzi, Paolo
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (01) : 117 - 126
12345